Impact of immune checkpoint inhibitors on subsequent chemotherapy

被引：0
|
作者：
Watanabe, H. [1 ]
Kubo, T. [2 ]
Kudo, K. [3 ]
Minami, D. [4 ]
Murakami, T. [5 ]
Ochi, N. [6 ]
Ninomiya, T. [1 ]
Harada, D. [7 ]
Yasugi, M. [8 ]
Takeda, H. [9 ]
Ichihara, E. [1 ]
Ohashi, K. [1 ]
Hotta, K. [10 ]
Tabata, M. [2 ]
Maeda, Y. [11 ]
Kiura, K. [1 ]
机构：
[1] Okayama Univ Hosp, Allergy & Resp Med, Okayama, Japan
[2] Okayama Univ Hosp, Ctr Clin Oncol, Okayama, Japan
[3] Iwakuni Med Ctr, Resp Med, Iwakuni, Japan
[4] Okayama Med Ctr, Resp Med, Okayama, Japan
[5] Japanese Red Cross Soc Himeji Hosp, Resp Med, Himeji, Hyogo, Japan
[6] Kawasaki Med Sch, Gen Internal Med 4, Okayama, Japan
[7] Shikoku Canc Ctr, Resp Med, Matsuyama, Ehime, Japan
[8] Chugoku Cent Hosp, Resp Med, Fukuyama, Hiroshima, Japan
[9] Tsuyama Chuo Hosp, Resp Med, Tsuyama, Japan
[10] Okayama Univ Hosp, Innovat Clin Med, Okayama, Japan
[11] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Hematol & Oncol, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439P
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [31] Characterization of the impact of immune checkpoint inhibitors on platelet activation and aggregation
    Schlueter, Julian
    Cunningham, Sarah
    Zimmermann, Robert
    Achenbach, Susanne
    Kramer, Rafaela
    Erdmann, Michael
    Beckmann, Malte
    Heinzerling, Lucie
    Hackstein, Holger
    IMMUNOBIOLOGY, 2023, 228 (01)
  • [32] Immune checkpoint inhibitors-induced autoimmunity: The impact of gender
    Triggianese, Paola
    Novelli, Lucia
    Galdiero, Maria Rosaria
    Chimenti, Maria Sole
    Conigliaro, Paola
    Perricone, Roberto
    Perricone, Carlo
    Gerli, Roberto
    AUTOIMMUNITY REVIEWS, 2020, 19 (08)
  • [33] Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer
    Kuo, Chih-Hsi Scott
    Wang, Chin-Chou
    Huang, Yu-Chen
    Pavlidis, Stelios
    Liu, Chien-Ying
    Ko, How-Wen
    Chung, Fu-Tsai
    Lin, Tin-Yu
    Wang, Chih-Liang
    Guo, Yi-Ke
    Yang, Cheng-Ta
    THORACIC CANCER, 2019, 10 (05) : 1158 - 1166
  • [34] Characterization of the immune cell profile in metastatic nasopharyngeal carcinoma treated with chemotherapy and immune checkpoint inhibitors
    Kuo, Yung-Chia
    Tai, Tzong-Shyuan
    Yang, Huang-Yu
    Lui, Kar-Wai
    Chao, Yin-Kai
    Lee, Li-Yu
    Huang, Yenlin
    Fan, Hsien-Chi
    Lin, An-Chi
    Hsieh, Chia-Hsun
    Yang, Zhangung
    Chang, Kai-Ping
    Lin, Chien-Yu
    Wang, Hung-Ming
    Hsu, Cheng-Lung
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (12):
  • [35] Clinical Outcomes of Non-Small Cell Lung Cancer Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitors, EGFR Tyrosine Kinase Inhibitors, Chemotherapy and Immune Checkpoint Inhibitors, or Chemotherapy Alone
    Dohm, A. E.
    Tang, J.
    Mills, M. N.
    Perez, B. A.
    Robinson, T. J.
    Creelan, B.
    Gray, J.
    Etame, A. B.
    Vogelbaum, M.
    Forsyth, P.
    Yu, H. H. M.
    Oliver, D. E.
    Ahmed, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E567 - E567
  • [36] Subsequent Systemic Therapy following Platinum and Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
    Hong, Joohyun
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Park, Se Hoon
    BIOMEDICINES, 2022, 10 (08)
  • [37] Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone
    Dohm, Ammoren E.
    Tang, Joseph D.
    Mills, Matthew N.
    Liveringhouse, Casey L.
    Sandoval, Maria L.
    Perez, Bradford A.
    Robinson, Timothy J.
    Creelan, Benjamin C.
    Gray, Jhanelle E.
    Etame, Arnold B.
    Vogelbaum, Michael A.
    Forsyth, Peter
    Yu, Hsiang-Hsuan Michael
    Oliver, Daniel E.
    Ahmed, Kamran A.
    JOURNAL OF NEUROSURGERY, 2023, 138 (06) : 1600 - 1607
  • [38] Adding immune-checkpoint inhibitors to chemotherapy extends survival in endometrial cancer
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (06) : 353 - 353
  • [39] Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients
    Ma, Junxun
    Sun, Danyang
    Wang, Jinliang
    Han, Chun
    Qian, Yuanyu
    Chen, Guangying
    Li, Xiaoyan
    Zhang, Juan
    Cui, Pengfei
    Du, Wushuang
    Wu, Zhaozhen
    Chen, Shixue
    Zheng, Xuan
    Yue, Zhichao
    Song, Jia
    Gao, Chan
    Cai, Shangli
    Hu, Yi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (03) : 365 - 372
  • [40] Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors
    Muraro, Elena
    Vinante, Lorenzo
    Fratta, Elisabetta
    Bearz, Alessandra
    Hoefler, Daniela
    Steffan, Agostino
    Baboci, Lorena
    CANCERS, 2023, 15 (09)
12345